200 related articles for article (PubMed ID: 9143806)
1. Proteoglycans contain a 4.6-A repeat in corneas with macular dystrophy: II. Histochemical evidence.
Quantock AJ; Klintworth GK; Schanzlin DJ; Lenz ME; Thonar EJ
Cornea; 1997 May; 16(3):322-6. PubMed ID: 9143806
[TBL] [Abstract][Full Text] [Related]
2. Proteoglycans contain a 4.6 A repeat in muscular dystrophy corneas: x-ray diffraction evidence.
Quantock AJ; Klintworth GK; Schanzlin DJ; Capel MS; Lenz ME; Thonar EJ
Biophys J; 1996 Apr; 70(4):1966-72. PubMed ID: 8785355
[TBL] [Abstract][Full Text] [Related]
3. Atypical composition and ultrastructure of proteoglycans in the mouse corneal stroma.
Young RD; Tudor D; Hayes AJ; Kerr B; Hayashida Y; Nishida K; Meek KM; Caterson B; Quantock AJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1973-8. PubMed ID: 15914611
[TBL] [Abstract][Full Text] [Related]
4. Macular corneal dystrophy: the macromolecular structure of the stroma observed using electron microscopy and synchrotron X-ray diffraction.
Meek KM; Quantock AJ; Elliott GF; Ridgway AE; Tullo AB; Bron AJ; Thonar EJ
Exp Eye Res; 1989 Dec; 49(6):941-58. PubMed ID: 2515072
[TBL] [Abstract][Full Text] [Related]
5. Sulfated proteoglycans in the human lamina cribrosa.
Sawaguchi S; Yue BY; Fukuchi T; Iwata K; Kaiya T
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2388-98. PubMed ID: 1634336
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan molecules in keratoconus corneas.
Sawaguchi S; Yue BY; Chang I; Sugar J; Robin J
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1846-53. PubMed ID: 2032806
[TBL] [Abstract][Full Text] [Related]
7. Distribution and characterization of sulfated proteoglycans in the human trabecular tissue.
Tawara A; Varner HH; Hollyfield JG
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2215-31. PubMed ID: 2793361
[TBL] [Abstract][Full Text] [Related]
8. Macular corneal dystrophy type II: multiple studies on a cornea with low levels of sulphated keratan sulphate.
Quantock AJ; Fullwood NJ; Thonar EJ; Waltman SR; Capel MS; Ito M; Verity SM; Schanzlin DJ
Eye (Lond); 1997; 11 ( Pt 1)():57-67. PubMed ID: 9246278
[TBL] [Abstract][Full Text] [Related]
9. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
Klintworth GK; Smith CF
Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892
[TBL] [Abstract][Full Text] [Related]
10. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy.
Plaas AH; West LA; Thonar EJ; Karcioglu ZA; Smith CJ; Klintworth GK; Hascall VC
J Biol Chem; 2001 Oct; 276(43):39788-96. PubMed ID: 11514545
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody.
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO
Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360
[TBL] [Abstract][Full Text] [Related]
12. Morphometry of cupromeronic blue-stained proteoglycan molecules in animal corneas, versus that of purified proteoglycans stained in vitro, implies that tertiary structures contribute to corneal ultrastructure.
Scott JE
J Anat; 1992 Feb; 180 ( Pt 1)(Pt 1):155-64. PubMed ID: 1452471
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of a large proteoglycan in human lung alveoli.
van Kuppevelt TH; van Beuningen HM; Rutten TL; van den Brule AJ; Kuyper CM
Eur J Cell Biol; 1986 Jan; 39(2):386-90. PubMed ID: 2420593
[TBL] [Abstract][Full Text] [Related]
14. X-ray diffraction and transmission electron microscopy of Morquio syndrome type A cornea: a structural analysis.
Rawe IM; Leonard DW; Meek KM; Zabel RW
Cornea; 1997 May; 16(3):369-76. PubMed ID: 9143815
[TBL] [Abstract][Full Text] [Related]
15. Synchrotron X-ray diffraction in atypical macular dystrophy.
Quantock AJ; Meek KM; Thonar EJ; Assil KK
Eye (Lond); 1993; 7 ( Pt 6)():779-84. PubMed ID: 8119433
[TBL] [Abstract][Full Text] [Related]
16. Analysis of high-angle synchrotron x-ray diffraction patterns obtained from macular dystrophy corneas.
Quantock AJ; Meek KM; Thonar EJ
Cornea; 1992 May; 11(3):185-90. PubMed ID: 1587124
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the stromal architecture and depletion of keratan sulphate proteoglycans in oedematous human corneas: histological, immunochemical and X-ray diffraction evidence.
Quantock AJ; Meek KM; Brittain P; Ridgway AE; Thonar EJ
Tissue Cell; 1991; 23(5):593-606. PubMed ID: 1723226
[TBL] [Abstract][Full Text] [Related]
18. A comparative biochemical and ultrastructural study of proteoglycan-collagen interactions in corneal stroma. Functional and metabolic implications.
Scott JE; Bosworth TR
Biochem J; 1990 Sep; 270(2):491-7. PubMed ID: 2119175
[TBL] [Abstract][Full Text] [Related]
19. Cytochemical localisation and characterisation of proteoglycans (glycosaminoglycans) in the epithelial-stromal interface of the seminal vesicle of the guinea pig.
Chan L; Wong YC
J Anat; 1992 Feb; 180 ( Pt 1)(Pt 1):41-56. PubMed ID: 1280636
[TBL] [Abstract][Full Text] [Related]
20. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan.
Hassell JR; Newsome DA; Krachmer JH; Rodrigues MM
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3705-9. PubMed ID: 6447876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
